201103897 六、發明說明: 【發明所屬之技術領域】 霉酚酸之化學結構如下式(丨)所示:201103897 VI. Description of the invention: [Technical field to which the invention belongs] The chemical structure of mycophenolic acid is as follows:
霉酶酸是一種免疫抑制劑(immunosuppressant ),用於器官移 植,避免器官接受者對新植入的器官產生排斥。霉酚酸係次黃嘌 呤核音單峨酸脱虱酶(inosine monophosphate dehydrogenase, IMPDH)抑制劑’可經由控制嗓呤(purine)的重新合成(也即v〇 synthesis)途徑’抑制淋巴τ細胞與B細胞的活化增生。此外, 霉酚酸也具有抗腫瘤(antitumor)、抗霉菌(amifimgal)、抗細菌 (antibacterial)以及抗病毒(antivirai)的特性(參閱專利us 2008/0293110 A1與文中所提列之參考文獻與專利)。 【先前技術】 在專利US 2008/0293110 A1中,發表霉紛酸的單離方法,係 利用適當的驗與發酵液(fermentation broth)混合,授拌、過濾後, 經由酸化、析晶、過遽後得到的霉驗酸,以甲苯再結純化後,純 度可達到99.2%。 3 201103897 在專利WO 2009/040828 A1中,發表霉酚酸的純化方法,係 先利用低體積莫耳濃度的碳酸鈉水溶液,萃取出霉酚酸之乙酸乙 酯溶液中的極性(polar)不純物;之後’再以氫氧化鈉水溶液, 對霉酚酸的乙酸乙酯溶液進行連續萃取;合併後的氫氧化鈉萃取 液,再以正丁醇萃取出霉酚酸之乙酸乙酯溶液中非極性 (non_polar)的不純物。萃取後的氫氧化鈉水溶液,經酸化、萃 取、有機溶劑再結,得到純化後的霉酚酸;在此篇專利的實施例 •(一)中,收率為60%,其中,霉酚酸中的不純物含量最高者為 0.12% ;於實施例(二)中,收率僅50%,其中,霉酚酸中有數個 不純物含量介於0.10〜0.12% ;於實施例(三)中,收率雖然可達 80% ’但是,霉酚酸中仍有數個不純物含量介於〇 1〇〜〇 13〇/〇。 雖然,依專利WO 2009/040828 A1中發表的純化方法,得到 的霉盼酸,其純度高於專利US 2008/0293110 A1中發表的方法, 但是’其中所含有之個別不純物含量仍然高於〇 1〇%之邊界範圍之 修上’根據1CH指引(ICH guidelines),凡個別不純物大於〇.1〇〇/0以 上,須將其單離出並進行結構鑑定,因此,此法仍非理想的純化 方法。 【發明内容】 按霉酚酸(1) ’係經由發酵製程所產生之化合物,利用一般有 機溶劑再結的方法,無法有效降低伴隨著霉酚酸〇)所產生的不 純物(位於RRT 〇.83, 3.65, 5.73, 5 87, 6 〇3 )。然而,在霉紛酸⑴ 4 201103897 的前體藥物霉紛酸鈉鹽⑴的製傷條件中,霉紛酸⑴的純度 對霉紛酸鈉鹽的品質則具有絕對的影響。 ,本發明係將霉_轉變為霉__衍生物,霉紛酸賴 街生物與_酸之間物性上的差異,_霉雜中不易去除的不 純物。所得到的霉__員衍生物,在驗金屬氫氧化物(a脑 hydroxide)水;谷液中進行水解反應,經酸化、萃取、濃縮、再結 等步驟’得到霉酴酸,其巾,不純物的含量皆遠低於〇1〇%以下, •收率 86.5%。 純化後的霉酚酸與含鈉的有機鹼或無機鹼進行皂化反應後, 可得到高純度的霉紛酸鈉鹽’其中,不純物的含量皆遠低於〇]〇% 以下。 本發明係利用酯化(esterification)反應,將欲純化之霉酚酸 (1)轉變為霉酚酸酯類衍生物(3),如流程丨所示,利用霉酚酸 (1)與霉酚酸酯類衍生物(3)之間物性上的差異,降低原本在 •霉酚酸(1)中不易移除的不純物。純化後的霉酚酸酯類衍生物 (3) ’於鹼金屬氫氧化物水溶液中進行水解反應後,經由酸化、 萃取、濃縮、再結等步驟,得到霉酚酸(1),其中,不純物(位 於 RRT 0.83, 3.65, 5.73, 5.87, 6.03 )含量皆遠低於 〇.10%以下。 5 201103897Mycophenolic acid is an immunosuppressant used for organ transplantation to prevent organ recipients from rejecting newly implanted organs. The mycophenolic acid hypoxanthine monophosphate dehydrogenase (IMDH) inhibitor can inhibit lymphatic tau cells by controlling the purine re-synthesis (ie, v〇synthesis) pathway. Activated proliferation of B cells. In addition, mycophenolic acid also has antitumor, amifimal, antibacterial, and antivirai properties (see patent US 2008/0293110 A1 and references and patents cited herein) ). [Prior Art] In the patent US 2008/0293110 A1, a method for the separation of moldy acid is disclosed, which is mixed with a fermentation broth by an appropriate test, and after being mixed and filtered, it is acidified, crystallized, and passed through. After the obtained acid test, after purification by toluene, the purity can reach 99.2%. 3 201103897 In the patent WO 2009/040828 A1, a method for purifying mycophenolic acid is disclosed, which first extracts a polar impurity in a solution of mycophenolic acid in an ethyl acetate solution using a low volume molar aqueous solution of sodium carbonate; After that, the extract of mycophenolic acid in ethyl acetate was continuously extracted with an aqueous solution of sodium hydroxide; the combined sodium hydroxide extract was extracted with n-butanol to extract non-polarity in the ethyl acetate solution of mycophenolic acid ( Non_polar) of impurities. The extracted aqueous sodium hydroxide solution is acidified, extracted, and re-agglomerated in an organic solvent to obtain purified mycophenolic acid; in the example (1) of this patent, the yield is 60%, wherein mycophenolic acid The highest impurity content is 0.12%; in the embodiment (2), the yield is only 50%, wherein the amount of impurities in the mycophenolic acid is between 0.10 and 0.12%; in the embodiment (3), Although the rate can reach 80% 'but, there are still several impurities in the mycophenolic acid content between 〇1〇~〇13〇/〇. Although, according to the purification method disclosed in the patent WO 2009/040828 A1, the obtained mycophenolic acid has a purity higher than that published in the patent US 2008/0293110 A1, but 'the content of the individual impurities contained therein is still higher than 〇1. 〇% of the boundary range of the repair "according to the 1CH guidelines (ICH guidelines), where the individual impurities are greater than 〇.1〇〇 / 0 or more, they must be separated and structurally identified, therefore, this method is still not ideal purification method. SUMMARY OF THE INVENTION According to the mycophenolic acid (1) 'system through the fermentation process, using the general organic solvent re-cure method, can not effectively reduce the impurities produced by the mycophenolate mofetil (located in RRT 〇.83 , 3.65, 5.73, 5 87, 6 〇 3 ). However, in the wounding conditions of the prodrug sodium salt (1) of mycophenolic acid (1) 4 201103897, the purity of the acid (1) has an absolute influence on the quality of the sodium salt. In the present invention, the mold is converted into a mildew-_derivative, and the difference in physical properties between the sulphate acid and the _acid is _yield which is difficult to remove in the mold. The obtained mildew derivative is subjected to a hydrolysis reaction in a water of a metal hydroxide (a brain hydroxide); a step of acidification, extraction, concentration, re-knotification, etc. to obtain a mycophenolic acid, a towel thereof, The content of impurities is much lower than 〇1〇%, and the yield is 86.5%. After the purified mycophenolic acid is saponified with a sodium-containing organic or inorganic base, a high-purity sodium sulphate salt can be obtained, wherein the content of the impurities is much lower than 〇] 〇 % or less. The present invention utilizes an esterification reaction to convert the mycophenolic acid (1) to be purified into a mycophenolate derivative (3), as shown in the scheme, using mycophenolic acid (1) and mycophenolic acid. The difference in physical properties between the acid ester derivatives (3) reduces the impurities which are not easily removed in the mycophenolic acid (1). After the purified mycophenolate ester derivative (3) 'hydrolyzed in an aqueous alkali metal hydroxide solution, the mycophenolic acid (1) is obtained by acidification, extraction, concentration, re-cylinder, etc., wherein the impurity (Located at RRT 0.83, 3.65, 5.73, 5.87, 6.03) are well below 〇.10%. 5 201103897
流程1Process 1
3b: R=CH2〇H3 3c: R=CH2CH2CH3 3d: R=CH(CH3)23b: R=CH2〇H3 3c: R=CH2CH2CH3 3d: R=CH(CH3)2
3e: R=CH,CH,-|^〇3e: R=CH, CH, -|^〇
Hydrolysis | HydrolysisHydrolysis | Hydrolysis
本發明之霉酚酸(1 )純化製程包含下述反應與過程之組合(戋 步驟): (1)醋化反應 將醇類(alcohol) (4)與霉酚酸(1),在有機酸對—曱笨磺 酸(Wra-toluenesulfonic acid,簡稱p-TSA) (5)的催化下,進行 鲁酯化反應’產生霉齡酸烧酯(alkyl mycophenolate) (3a-d),霉紛 酸烷酯(3a-d)可在醇類(4)溶液中析出而得。 此外,所得到的霉盼酸酯類衍生物(3)亦可於醇類(4)中 進行再結純化;於醇類(4)中再結純化後的霉酚酸酯類衍生物 (3),可以更有效地提高水解後所產生之霉酚酸的純度。 本發明即是將欲純化之霉酚酸(1),轉變為霉酚酸酯類衍生 物(3),利用霉酚酸(D與霉酚酸酯類衍生物(3)之間物性上 的差異’降低原本在霉紛酸(1)中不易移除的不純物。然而,有 6 201103897 些醇類分子太大,如2· (4-嗎琳)乙醇(2_(4_m()rph()linyl)ethan()1) (6)’無法直接與霉酚酸(1)進行酯化反應,因此,將霉酚酸〇) 轉變為霉驗酸烧S旨(3a-d )後,再與其進行醋交換 (transesterification)反應,以得到所欲之酯類衍生物,反應如流 程1所示。 將2- (4-嗎琳)乙醇(6)與霉酚酸烷酯(3a_d)在二丁基錫 氧化物(dibutyltinoxide)的催化下,於曱苯中進行酯交換反應, • 產生霉酚酸2_ (4_嗎啉)乙酯(3e)。 所產生之霉紛酸2- (4·嗎琳)乙醋(3e),酸化後溶於水層, 經有機溶劑,如乙酸乙酷’萃取後,可以有效移去原本霉盼酸中 (1)不易去除之不純物。經由驗化、有機溶劑萃取、濃縮、乾燥 後之霉酴酸2- (4-嗎淋)乙醋(3e),於水解後可得到高純度的霉 盼酸。 _ (2)霉酚酸酯類衍生物(3)的水解反應 霉酚酸酯類衍生物(3)於鹼金屬氫氧化物水溶液中進行水解 反應後,再經由酸化、萃取、漠縮、再結等步驟,得到霉齡酸⑴, 其中’不純物的含量皆遠低於0.10〇/〇以下。 霉酚酸酯類衍生物(3)的水解過程中,鹼金屬氫氧化物的當 量數可由LOW當量’以3.〇〜Μ當量最適合。驗金屬氣氧化物 可為氫氧化鐘、氫氧化納以及氫氧化鉀,其中以氣氧化納最適合。 反應時間可由2〜36小時,以4〜24小時_合。反應溶液酸化後 7 201103897 的pH值可由0.3〜3.5,以0.5〜2·0最適合。 本發明即是利用霉紛酸(1)與霉酴酸醋類衍生物(3)之間 物性上的差異’來降低霉齡酸中不易移除的不純物,以得到品質 高、不純物含量低的霉酚酸(1)。 霉酚酸酯類衍生物(3)在醇類(4)中再結純化後,可以使 水解後產生的霉酚酸(1) ’純度更有效地提高之外,霉酚酸烷酯 鲁 (3a-d)與2_ (4-嗎啉)乙醇(6) ’在進行酯交換反應後,所產生 的霉酚酸2-(4-嗎啉)乙酯(3e)’於水解後可得到高純度的霉酚 酸(1) ’其中,不純物含量皆低於0.05%。 除了發酵製程所伴隨而生的不純物之外,霉紛酸(^)在經石夕 藻土(celite)過濾的純化過程中,常會出現一般有機溶劑再結不 易去除的深紫色。本發明係利用對—甲苯磺酸(5),將其與霉酚 酸(1)的再結溶液混合,析晶、過濾後,即可得到白色之霉酚酸 # (1)固體。 於霉酚酸(1)的有機溶劑再結過程中,對—甲苯磺酸(5) 的使用量可為G.GG1〜G.2G當量,其中,以_2〜q 15當量最適合。 在霉盼酸⑴的前體藥物霉紛酸鈉鹽⑴的製備條件中, 霉酴酸⑴的純度對霉紛酸納鹽⑴的品質具有決定性的影響。 將純化後的_酸⑴與含_有機驗或無鑛進行4化反應, 得到的霉酴酸納鹽(2),其中,不純物的含量皆遠低於〇1〇%以下。 8 201103897 【實施方式】 本發明可由以下諸實施例說明其製程,但本發明之範圍並非侷 限在以下所述之實施例。 於下列各實施例中所述及之反應,皆利用高效能液相層析儀 (HPLC,Waters)對反應起始物、中間體以及產物進行分析,高效 能液相層析儀之分析條件如下:The mycophenolic acid (1) purification process of the present invention comprises the following combination of reaction and process (戋 step): (1) vineification reaction of alcohol (alcohol) (4) with mycophenolic acid (1) in organic acid Under the catalysis of Wra-toluenesulfonic acid (p-TSA) (5), the esterification reaction produces 'alkyl mycophenolate (3a-d), mycophenolate The ester (3a-d) can be obtained by precipitation in an alcohol (4) solution. Further, the obtained mycophenolate derivative (3) can also be re-purified in the alcohol (4); and the mycophenolate derivative after re-purification in the alcohol (4) (3) ), the purity of mycophenolic acid produced after hydrolysis can be more effectively improved. The invention converts the mycophenolic acid (1) to be purified into the mycophenolate ester derivative (3), and utilizes the physical property between the mycophenolic acid (D and the mycophenolate ester derivative (3). The difference 'reduced the impurities that were not easily removed in the soy acid (1). However, there are 6 201103897 some alcohol molecules are too large, such as 2 · (4- morphine) ethanol (2_(4_m()rph()linyl) )ethan()1) (6) 'The esterification reaction cannot be directly carried out with mycophenolic acid (1). Therefore, after changing the mycophenolate mofetil) to the mold test acid (S), (3a-d), The transesterification reaction is carried out to obtain the desired ester derivative, and the reaction is shown in Scheme 1. 2-(4-Merlin) ethanol (6) and mycophenolate (3a_d) are transesterified in terpene benzene under the catalysis of dibutyltinoxide. • Produce mycophenolic acid 2_ ( 4_morpholine)ethyl ester (3e). The resulting mildew acid 2-(4·Merlin) ethyl vinegar (3e) is dissolved in the water layer after acidification, and can be effectively removed by extraction with an organic solvent such as ethyl acetate (1) ) Impure that is not easy to remove. After the hydrolysis, the organic solvent extraction, concentration, and drying of the mycophenolic acid 2-(4-loryl)acetic acid (3e), high-purity mycophenolic acid can be obtained after hydrolysis. _ (2) hydrolysis reaction of mycophenolate derivatives (3) Mycophenolate derivatives (3) are hydrolyzed in an aqueous alkali metal hydroxide solution, followed by acidification, extraction, condensation, and further In the step of knotting, a mycophenolic acid (1) is obtained, wherein the content of the 'impurity is far below 0.10 〇 / 〇. In the hydrolysis of the mycophenolate derivative (3), the amount of the alkali metal hydroxide can be most suitably determined by the LOW equivalent of 3. 〇 to Μ. The metal oxide can be a hydroxide, sodium hydroxide or potassium hydroxide, of which sodium is most suitable for gas oxidation. The reaction time can be from 2 to 36 hours to 4 to 24 hours. After the acidification of the reaction solution, the pH of 7201103897 can be 0.3~3.5, and 0.5~2·0 is most suitable. The invention utilizes the difference in physical properties between the mycophenolic acid (1) and the mycophenolic acid vinegar derivative (3) to reduce the impurities which are not easily removed in the moldy acid, so as to obtain high quality and low impurity content. Mycophenolic acid (1). The refining of the mycophenolate ester derivative (3) in the alcohol (4) can further improve the purity of the mycophenolic acid (1)' produced after the hydrolysis, and the mycophenolate molybdenum ( 3a-d) and 2_(4-morpholine)ethanol (6)' After the transesterification reaction, the resulting mycophenolic acid 2-(4-morpholine)ethyl ester (3e)' can be obtained after hydrolysis. The purity of mycophenolic acid (1) 'where the impurities are less than 0.05%. In addition to the impurities produced by the fermentation process, the mild acid (^) in the purification process filtered through celite often has a deep purple color which is not easily removed by general organic solvents. In the present invention, p-toluenesulfonic acid (5) is used, and it is mixed with a re-synthesis solution of mycophenolic acid (1), and after crystallization and filtration, a white fungus phenolic acid # (1) solid can be obtained. In the re-junction process of the organic solvent of mycophenolic acid (1), the amount of p-toluenesulfonic acid (5) used may be G.GG1 to G.2G equivalent, and the most suitable one is _2 to q15 equivalent. In the preparation conditions of the prodrug sodium salt (1) of the mycophenolic acid (1), the purity of the mycophenolic acid (1) has a decisive influence on the quality of the solubilized sodium salt (1). The purified oxalic acid (1) is reacted with the organic-containing or non-mineralized 4-carbonated sodium salt (2), wherein the content of the impurities is much lower than 〇1〇%. 8 201103897 [Embodiment] The present invention can be illustrated by the following embodiments, but the scope of the present invention is not limited to the embodiments described below. In the reactions described in the following examples, the reaction starting materials, intermediates and products were analyzed by high performance liquid chromatography (HPLC, Waters). The analytical conditions of the high performance liquid chromatography were as follows. :
1·管柱(Column). ZORBAX,150 X 4.6 mm,Agilent C8 2·管柱溫度:45°C 3. 流動相(Mobile phase):混合 350 毫升乙腈(acet〇nitrile)、650 毫升純水以及2.0毫升三乙胺(triethylamine),以85%構酸水 溶液調混合溶液之pH值至5.3,震盪後使用。 4. 流速(Flowrate) : 0.8 mL/min. 5·偵測波長:250nm1. Column (Column). ZORBAX, 150 X 4.6 mm, Agilent C8 2. Column temperature: 45 ° C 3. Mobile phase: Mix 350 ml of acetonitrile (nit〇nitrile), 650 ml of pure water and 2.0 ml of triethylamine, the pH of the mixed solution was adjusted to 5.3 with 85% aqueous acid solution, and used after shaking. 4. Flowrate: 0.8 mL/min. 5. Detection wavelength: 250 nm
6.注射體積:10 uL 於此條件下’經由液相層析儀進行分析所顯示出之不純物, 其吸收峰的相對滯留時間(relative retention times,RRT)之誤差範 圍在-0.05至+0.05之間。 實施例1 (0 合成霉酚酸甲酯(MethylMycophenolate) 於反應瓶中加入霉酴酸(9.5克,29.7毫莫耳,其中,不純物 位於 RRT 0.83, 3.65, 6.03 的含量分別為 〇_16%,0.54%,0.54%)與 9 201103897 甲醇(250毫升),室溫下授拌反應混合物至澄清溶液,加入對— 甲苯猶(0.42克,2.4毫莫耳)。加熱反應溶液至迴流,攪拌2 小時。㊉壓蒸餾出甲醇(15〇毫升),降溫析晶,液溫達25。〇時以 冰水浴冷卻,並於液溫為時過濾,瓶壁與溼固體以冰甲醇洗, 屋固體於60 C乾燥’得到白色固體產物(9·4克,28.0毫莫耳), 產率94.4%。 (2)霉酚酸甲酯的水解 室溫下,於反應瓶中加入氫氧化納(3 8克,95 〇毫莫耳)與 純水(笔升)’授拌混合物至澄清水溶液。加入霉紛酸曱酯(9.0 克27.0毫莫耳),至溫下授拌21小時。反應溶液以乙酸乙酯(1〇〇 毫升)萃取,丟棄有機層。水層以32%鹽酸水溶液調ρΗ值至丨5, 以乙酸乙r目⑽毫升)萃取兩次。合併乙酸乙醋溶液,常壓下蒸 鶴出乙酸乙S旨(Π0毫升)’降溫析晶,液溫達坑時以冰水浴冷 卻’並於液溫rc時過滤’瓶壁與座固體以冰乙酸乙醋洗,渔固體 於60C乾燥,得到白色固體產物(7 9克,24 7毫莫耳,其中,不 純物位於RRT 0.83, 3·65, 6.G3的含量分別為G.G5%,〇.〇3%, 0.02%),產率 91.6% 〇 實施例2 (1)合成霉酚酸甲酯 於反應瓶中加入霉酚酸(3〇.〇克,93 8毫莫耳,其中,不純 物位於 RRT O.83, 3.65, π 的含量分別為 〇 2〇%,〇 s6%,〇 42%) 201103897 與甲醇(150毫升)’室溫下攪拌反應混合物至澄清溶液,加入對 —曱笨續酸(1.26克’ 7.3毫莫耳)。加熱反應溶液至迴流,擾拌2 小時。降溫析晶,室溫下以冰水浴冷卻,並於液溫為2。〇時過濾, 瓶壁與溼固體以冰曱醇洗,溼固體於60°C乾燥,得到白色固體產 物(28.8克,86.2毫莫耳),產率95.2%。 (2)合成霉驗酸2- (4-嗎琳)乙醋 於反應瓶中加入霉酚酸甲酯(2〇.〇克,59.9毫莫耳)、甲苯(74 4 •克)、2-(4-嗎琳)乙醇(8.3克’63.1毫莫耳)與2-丁基錫氧化物 (1.5克,6_0毫莫耳),加熱反應混合物至迴流,攪拌丨小時。降 溫,於反應溶液内溫46。(:時,加入2-丁基錫氧化物(6.0克,24.0 毫莫耳)’加熱反應混合物至迴流,於迴流溫度下,攪拌4〇小時。 降溫,於反應;谷液内溫48°C時,加入活性碳(1.〇克),授拌j小 時。加入乙酸乙酯(22.9克),攪拌5分鐘後,經矽藻土(ceUte) 過遽,瓶壁以乙酸乙醋(22.9克)洗,收集、合併遽液與洗液, 釀以純水(45.8克)洗。將有機溶液與純水(45 8克)混合、鮮, 以32%鹽酸水溶液調pH值至162,靜置分層,丢棄有機層,水層 以乙酸乙酯(45.8克)洗兩次。將水層與二氣甲烧(61 4克)混 合、攪拌’再以45%氫氧化鈉水溶液調pH值至1〇 83,靜置分層’ 收集有機層,水層以二氣甲烧(61.4克)萃取,合併有機層,以 飽和破躺水麵洗。將錢層濃縮至乾,固體雜物於6〇。〇 乾燥後’得到固體產物⑵.5克,49 6毫莫耳),產率82 8〇/〇。 (3)霉酌·酸2- (4-嗎琳)乙g旨的水解 201103897 室溫下’於反應瓶令加入氫氧化鈉(3 2克,78 8毫莫耳)與 純水(100 ί升),擾拌混合物至澄清水溶液。加入霉齡酸2· (4、_ 嗎琳)乙醋(10.0克,23.1毫莫耳),室溫下授拌4小時。反應溶 液以乙酸乙醋⑼毫升)萃取兩次,丟棄有機層,將水層與乙酸 乙酯(100毫升)混合並攪拌’以32〇/〇鹽酸水溶液調阳值至136, 靜置分層,收集有機層,水層以乙酸乙g旨(50亳升)萃取。合併 乙酸乙酯溶液,常壓下蒸餾出乙酸乙酯(140毫升),降溫析晶, #液溫達25〇C時以冰水浴冷卻’並於液溫為2。〇時過據,瓶壁與渥 固體以冰乙酸乙醋洗,澄固體於6(rc麟,得到白色固體產物(69 克,21.6毫莫耳,其中,不純物位於RRT 〇 83, 3 65, 5 73的含量 分別為 0.03%,<0.01%,0.01%),產率 93.5%。 實施例3霉酚酸除色 將紫色的霉酚酸(30.0克,93.8毫莫耳)與丙酮(150毫升) φ 於反應瓶中混合、攪拌,加入對一曱苯續酸(0.62克,3.6毫莫耳)。 加熱混合物至迴流(紫色消失,溶液呈淡黃色)。降溫析晶,室溫 下以冰水浴冷卻,並於液溫為2。(:時過濾,瓶壁與溼固體以冰丙_ 洗,溼固體於60°C乾燥,得到白色霉酚酸(24克,75毫莫耳), 產率80%。 實施例4霉酚酸鈉鹽的製備 於反應瓶中加入霉酚酸(5克,15.63毫莫耳,其中,不純物 12 201103897 位於RRT 0.83, 3.65的含量分別為〇.〇5%,〇,〇ι%)、氫氧化鈉(0 625 克’ 15.63毫莫耳)以及曱醇(1〇〇毫升),加熱反應混合物至迴流, 搜拌0.5小時後,蒸餾出曱醇(70毫升)。降溫,於液溫為26。〇時 加入異丙醇(70毫升)’加熱混合物至迴流,並蒸餾出甲醇/異丙 醇混合液(70毫升)。降溫,於液溫為24°C時過濾,瓶壁與溼固 體以異丙醇洗,溼固體於60°C乾燥,得到固體產物霉酚酸鈉鹽 (5.12克,14.97亳莫耳,其中,不純物位於狀丁仏幻,3 65的含 Φ 量分別為 0.04%, <0.01%),產率 95.8%。 iSMl霉酚酸鈉鹽的製備(比較製程) 於反應瓶中加入霉酚酸(5克,15.63毫莫耳,其中,不純物 位於 RRT 0.83, 3.65, 5.87 的含量分別為 〇.ΐ7〇/ό,〇.56%, 0.48%)、氫 氧化鈉(0.625克,15.63毫莫耳)以及曱醇(100毫升),加熱反 應混合物至迴流,攪拌0.5小時後’蒸餾出甲醇(7〇毫升)。降溫, ® 於液溫為28°C時加入異丙醇(70毫升),加熱混合物至迴流,並 蒸餾出曱醇/異丙醇混合液(70毫升)。降溫,於液溫為25。〇時過 濾,瓶壁與溼固體以異丙醇洗,溼固體於60艽乾燥,得到固體產 物霉酚酸鈉鹽(4.8克’ 14.04毫莫耳,其中,不純物位於rrto 83, 3.65, 5.87 的含量分別為 0.13%,0.04%,0.04%),產率 89.8%。 本發明製得之霉盼酸或霉盼酸納鹽其不純物含量可低至 0.05%或低於0.05%以下’遠優於前述先前技術(pri〇r _)之不純物 201103897 高於0.10%以上者。 【圖式簡單說明】 無 【主要元件符號說明】 無6. Injection volume: 10 uL Under these conditions, the impurities displayed by the liquid chromatograph showed a relative retention time (RRT) with an error range of -0.05 to +0.05. between. Example 1 (0 Methyl Mycophenolate) Methyl Mycophenolate was added to the reaction flask (9.5 g, 29.7 mmol), wherein the impurities were at RRT 0.83, 3.65, 6.03, respectively, 〇_16%. 0.54%, 0.54%) and 9 201103897 methanol (250 ml), the reaction mixture was stirred at room temperature to a clear solution, and p-toluene (0.42 g, 2.4 mmol) was added. The reaction solution was heated to reflux and stirred for 2 hours. Distilled methanol (15 〇ml) under ten pressures, cooled and crystallized, the liquid temperature reached 25. When it was cooled, it was cooled in an ice water bath, and filtered at the liquid temperature. The bottle wall and the wet solid were washed with ice methanol, and the solid was 60. C dried to give a white solid product (9·4 g, 28.0 mmol), yield 94.4%. (2) Hydrolysis of methyl mycophenolate. Add sodium hydroxide (3 8 g) to the reaction flask at room temperature. , 95 〇 millimolar) and pure water (pen liter) 'mix the mixture to a clear aqueous solution. Add the mycophenolate ester (9.0 g 27.0 mmol), and mix for 21 hours at the temperature. The reaction solution is acetic acid B. The ester (1 ml) was extracted and the organic layer was discarded. The aqueous layer was adjusted with 32% aqueous hydrochloric acid. The value was reduced to 丨5 and extracted twice with ethyl acetate (10 ml). Combined with ethyl acetate vinegar solution, steaming cranes under normal pressure to produce acetic acid B. ((0 ml) 'cooling and crystallization, when the liquid temperature reaches the pit, cool with ice water bath' and filter at the liquid temperature rc 'bottle wall and seat solids to ice The acetic acid was washed with acetic acid and dried at 60 C to obtain a white solid product (79 g, 24 7 mmol), wherein the impurities were located at RRT 0.83, 3·65, 6. G3 were respectively G.G5%, 〇 〇3%, 0.02%), yield 91.6% 〇Example 2 (1) Synthetic methyl mycophenolate was added to the reaction flask with mycophenolic acid (3 〇. gram, 93 8 mmol, of which impurities Located at RRT O.83, 3.65, π content is 〇2〇%, 〇s6%, 〇42%) 201103897 with methanol (150 ml) 'The reaction mixture is stirred at room temperature to a clear solution, and added to the 曱 曱 曱Acid (1.26 g '7.3 mmol). The reaction solution was heated to reflux and spoiled for 2 hours. The crystal was cooled and cooled, and cooled in an ice water bath at room temperature, and the liquid temperature was 2. After filtration, the wall and wet solid were washed with ice-cold alcohol, and the wet solid was dried at 60 ° C to give a white solid product (28.8 g, 86.2 mmol), yield 95.2%. (2) Synthetic mold acid 2- (4-Merlin) ethyl vinegar was added to the reaction flask with methyl mycophenolate (2 〇. gram, 59.9 mmol), toluene (74 4 • gram), 2- (4-Merlin) Ethanol (8.3 g '63.1 mmol) and 2-butyltin oxide (1.5 g, 6_0 mmol), the reaction mixture was heated to reflux and stirred for hr. The temperature was lowered and the temperature was 46 in the reaction solution. (:, adding 2-butyltin oxide (6.0 g, 24.0 mmol)), heating the reaction mixture to reflux, stirring at reflux temperature for 4 hrs. Cooling, reaction; when the internal temperature of the solution is 48 ° C, Add activated carbon (1. g), and mix for j hours. Add ethyl acetate (22.9 g), stir for 5 minutes, then pass through celite (ceUte), and wash the bottle wall with ethyl acetate (22.9 g) Collect and combine the mash and the washing liquid, and wash it with pure water (45.8 g). Mix the organic solution with pure water (45 8 g), fresh, adjust the pH to 162 with 32% hydrochloric acid aqueous solution, and let stand. The organic layer was discarded, and the aqueous layer was washed twice with ethyl acetate (45.8 g). The aqueous layer was mixed with the second gas (6 4 g), stirred, and then adjusted to pH 1 with 45% aqueous sodium hydroxide. 〇83, static layering' The organic layer was collected, and the water layer was extracted with two gas (61.4 g), and the organic layer was combined and washed with saturated water. The layer was concentrated to dryness, and the solid matter was 6 〇. After drying, 'solid product (2). 5 g, 49 6 mmol) was obtained, yield 82 8 〇 / 〇. (3) Molybdenum acid 2- (4-Merlin) B hydrolysis of 201103897 At room temperature 'In the reaction bottle, add sodium hydroxide (32 g, 78 8 mmol) and pure water (100 ί l), disturb the mixture to a clear aqueous solution. Methyl vinegar 2 (4, _ _ _ _) vinegar (10.0 g, 23.1 mmol) was added and the mixture was stirred at room temperature for 4 hours. The reaction solution was extracted twice with ethyl acetate (9 ml), and then the organic layer was evaporated, and the aqueous layer was mixed with ethyl acetate (100 ml) and stirred to adjust the pH value to 136 with a 32 〇/〇 aqueous hydrochloric acid solution, and allowed to stand for stratification. The organic layer was collected, and the aqueous layer was extracted with ethyl acetate (50 liters). The ethyl acetate solution was combined, and ethyl acetate (140 ml) was distilled off under normal pressure, and the crystals were cooled and crystallized. When the liquid temperature reached 25 ° C, it was cooled in an ice water bath and the liquid temperature was 2. When the time was over, the bottle wall and the sputum solid were washed with glacial acetic acid acetonitrile, and the solid was solidified at 6 (rc lin) to give a white solid product (69 g, 21.6 mmol), wherein the impurities were located at RRT 〇83, 3 65, 5 The content of 73 was 0.03%, <0.01%, 0.01%, respectively, and the yield was 93.5%. Example 3 Mycophenolic Acid Decolorization Purple Mycophenolic Acid (30.0 g, 93.8 mmol) and acetone (150 ml) φ Mix and stir in the reaction flask, add p-benzoic acid (0.62 g, 3.6 mmol). Heat the mixture to reflux (purple disappears, the solution is pale yellow). Decrease the crystal, ice at room temperature The water bath is cooled and the liquid temperature is 2. (: Filtered, the wall of the bottle and the wet solid are washed with ice, and the wet solid is dried at 60 ° C to obtain white mycophenolic acid (24 g, 75 mmol). The rate was 80%.Example 4 Preparation of mycophenolate sodium salt Mycophenolic acid (5 g, 15.63 mmol) was added to the reaction flask, wherein the impurity 12 201103897 was located at RRT 0.83, 3.65, respectively, 〇.〇5% , 〇, 〇ι%), sodium hydroxide (0 625 g ' 15.63 mmol) and decyl alcohol (1 〇〇 ml), heating the reaction mixture to After stirring for 0.5 hour, decyl alcohol (70 ml) was distilled off, and the temperature was lowered at a liquid temperature of 26. At the time of hydrazine, isopropanol (70 ml) was added to heat the mixture to reflux, and methanol/isopropanol was distilled off. Liquid (70 ml), cooled, filtered at a liquid temperature of 24 ° C, the wall of the bottle and the wet solid were washed with isopropyl alcohol, and the wet solid was dried at 60 ° C to obtain a solid product, mycophenolate sodium salt (5.12 g, 14.97).亳莫耳, in which the impurity is located in the shape of Ding, the Φ content of 3 65 is 0.04%, <0.01%), the yield is 95.8%. Preparation of iSMl mycophenolate sodium salt (comparative process) in the reaction bottle Mycophenolic acid (5 g, 15.63 mmol) was added, wherein the impurities were located at RRT 0.83, 3.65, 5.87, respectively, 〇.ΐ7〇/ό, 〇.56%, 0.48%), sodium hydroxide (0.625 g) , 15.63 millimolar) and decyl alcohol (100 ml), the reaction mixture was heated to reflux, stirred for 0.5 hours, then 'distilled methanol (7 mL). Cooling, ® was added isopropanol at a liquid temperature of 28 ° C ( 70 ml), heat the mixture to reflux, and distill off the decyl alcohol/isopropanol mixture (70 ml). The temperature was 25. When filtering, the bottle wall and the wet solid were washed with isopropyl alcohol, and the wet solid was dried at 60 Torr to obtain a solid product, mycophenolate sodium salt (4.8 g ' 14.04 mmol, wherein the impurity was located at rrto 83, The content of 3.65, 5.87 is 0.13%, 0.04%, 0.04%), and the yield is 89.8%. The content of the impurity of the mycophenolic acid or the mycophenolic acid salt prepared by the invention may be as low as 0.05% or less and less than 0.05%. 'It is far superior to the aforementioned prior art (pri〇r _) of the impurities 201103897 higher than 0.10%. [Simple diagram description] None [Main component symbol description] None